B Cell Depletion: Rituximab in Glomerular Disease and Transplantation

B cells play a central role in the pathogenesis of many autoimmune diseases. Selective targeting can be achieved with the use of the monoclonal antibody rituximab. In addition to being a drug for non-Hodgkin's lymphoma, rituximab is also an FDA-approved treatment for refractory rheumatoid arthr...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinaki, S., Skalioti, C., Boletis, J.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919423/
https://www.ncbi.nlm.nih.gov/pubmed/24550930
http://dx.doi.org/10.1159/000356050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919423/
https://www.ncbi.nlm.nih.gov/pubmed/24550930
http://dx.doi.org/10.1159/000356050

Ejemplares similares